Utility of next generation sequencing to unequivocally establish clonality in synchronous vs metastatic endometrial and ovarian carcinomas
Background: Synchronous endometrial and ovarian carcinomas represent up to 10% of all endometrial and ovarian tumors. These are diagnostically challenging cases to determine if they represent dual primary tumors or related metastatic tumors. Case: A 48-year-old was diagnosed with synchronous primary...
Saved in:
Main Authors: | Michelle Greenman (Author), Stefania Bellone (Author), Tobias Hartwich (Author), Natalia Buza (Author), Alessandro D. Santin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
by: Michelle Greenman, et al.
Published: (2024) -
Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)
by: Alessandro D. Santin, et al.
Published: (2017) -
A Novel Single-Tube Next Generation Sequencing Assay for B-Cell Receptor Clonality Testing
by: Landon Pastushok, et al.
Published: (2024) -
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing
by: Jonathon H. Gralewski, et al.
Published: (2018) -
Efficient sequence of therapy for advanced and metastatic endometrial cancer
by: A. A. Rumyantsev
Published: (2022)